The Company intends to focus the Analyst Day discussion on ... antibody drug conjugates (tADC) platform. OS Therapies is a clinical stage oncology company focused on the identification ...

Equities researchers at Brookline Capital Management decreased their FY2025 earnings per share estimates for shares of OS Therapies in a research note issued to investors on Wednesday, April 2nd.

Independent MP Han Dong said Sunday morning he will not seek re-election in Don Valley North — a decision that comes one day after the Liberals announced they're running a candidate in the suburban ...

Liberal Leader and Prime Minister Mark Carney labelled Liberal candidate Paul Chiang’s call for other Chinese Canadians to ...

Equities researchers at Brookline Capital Management issued their Q1 2025 earnings per share estimates for OS Therapies in a research report issued to clients and investors on Wednesday, April 2nd.

Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community and platform, will release its first quarter 2025 financial results after the close of trading on the NYSE on Wednesday, ...

In addition, OS Therapies is advancing its next-generation Antibody Drug Conjugate (ADC) and Drug Conjugates (DC), known as tunable ADC (tADC), which features tunable, tailored antibody-linker ...